Efficacy and Safety of Rezivertinib (BPI-7711) in Patients With Locally Advanced or Metastatic/ Recurrent EGFR T790M-Mutated NSCLC: A Phase 2b Study
Shi, YK; Wu, SM; Wang, K; Cang, SD; Yao, WX; Fan, Y; Wu, L; Huang, MJ; Li, XY; Pan, YY; Yang, ZX; Zhu, B; Chen, GY; Shi, JH; Sun, ML; Fang, J; Wang, LJ; Chen, ZH; Liu, CL; Li, JZ; Liu, JW; Sun, SH; Zhao, YQ; Guo, YZ; Meng, ZL; Liu, ZF; Han, ZG; Lu, H; Ma, R; Hu, S; Zhao, GF; Liu, Z; Xie, CY; Zhong, DS; Zhao, H; Yu, HQ; Zhang, LZ; Bi, MH; Yi, SY; Guo, SL; Yi, TA; Li, W; Lin, YC; Shu, YQ; Chen, ZD; Guo, ZL; Greco, M; Wang, TT; Shen, HJ
Shi, YK (通讯作者)，Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc, Beijing, Peoples R China.;Shi, YK (通讯作者)，Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China.
JOURNAL OF THORACIC ONCOLOGY, 2022; 17 (11): 1306
